- Category
- Micro (2021-22)
- Udyam number
- UDYAM-TS-09-0018977

Highmaze Pharmaceuticals Private Limited
About Highmaze Pharmaceuticals Private Limited
Data last updated:
Highmaze Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 June 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U85100TG2021PTC152454. Its GSTIN is 36AAFCH8272F1ZF (Telangana).
The company has an authorised share capital of ₹20,000 and a paid-up capital of ₹20,000. It is led by directors Monalisha Mekap and Dankoju Sandhya Rani Achary.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No – 309 C Block 3rd Floor Concret Vivanta Madinaguda, Hyderabad, Telangana, India – 500049.
As per the financials filed for FY 2024, the company reported a revenue of ₹12.53 Lakh, a decline of 31% compared to the previous year. For the same year it recorded a net loss of ₹6.41 Lakh (net margin -51.2%) and EBITDA of -₹6.41 Lakh (EBITDA margin -51.2%).
Highmaze Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-09-0018977).
Company details
Recognitions & Rankings of Highmaze Pharmaceuticals
Contact details
Highmaze Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No – 309 C Block 3rd Floor Concret Vivanta Madinaguda, Hyderabad, Telangana, India – 500049
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Highmaze Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Highmaze Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Highmaze Pharmaceuticals Private Limited, buy the company report.
Financials of Highmaze Pharmaceuticals Private Limited
FY 2024 filings availableHighmaze Pharmaceuticals Private Limited reported revenue of ₹12.53 Lakh (down 31% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 31% in the latest year. EBITDA fell 68% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹6.41 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹6.41 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -51.2% | ||
| Net Profit Margin | -51.2% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Highmaze Pharmaceuticals Private Limited, buy the company report.
Board of directors of Highmaze Pharmaceuticals Private Limited
Highmaze Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Monalisha Mekap | Director | 23 Jun 2021 | 5 Years 4 Months | Current |
| Dankoju Sandhya Rani Achary | Director | 23 Jun 2021 | 5 Years 4 Months | Current |
Auditor
Highmaze Pharmaceuticals Private Limited is audited by BKK & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BKK & ASSOCIATES | FY 2022 | 015384S |
Shareholding
The shareholding of Highmaze Pharmaceuticals Private Limited is on record for FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Highmaze Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Highmaze Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Highmaze Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Highmaze Pharmaceuticals Private Limited has 1 active EPFO establishment as of Nov 15, 2026.
GST
Highmaze Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCH8272F1ZF | Telangana | Active | 20 Sep 2021 |
To see the full GST registrations and return filing status of Highmaze Pharmaceuticals Private Limited, buy the company report.
Recent activity
Highmaze Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Dankoju Sandhya Rani Achary was appointed as Director on 23 Jun 2021.
Frequently asked questions
Highmaze Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 June 2021 (5+ years old) and is registered under CIN U85100TG2021PTC152454.
Highmaze Pharmaceuticals has 2 current directors:
- Monalisha Mekap - Director
- Dankoju Sandhya Rani Achary - Director
The latest financial statements of Highmaze Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Highmaze Pharmaceuticals is 36AAFCH8272F1ZF, registered in Telangana.
The CIN (Corporate Identification Number) of Highmaze Pharmaceuticals is U85100TG2021PTC152454. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Highmaze Pharmaceuticals was incorporated on 23 June 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.
Dankoju Sandhya Rani Achary was appointed as Director on 23 Jun 2021. Monalisha Mekap was appointed as Director on 23 Jun 2021.
Yes, Highmaze Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-09-0018977).
The registered office of Highmaze Pharmaceuticals is at Plot No – 309 C Block 3rd Floor Concret Vivanta Madinaguda, Hyderabad, Telangana, India – 500049.
Highmaze Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

